Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men.
Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men.
复制标题
DOI:
10.1155/2013/750742
复制
发表时间:
2013
影响因子:
4.6
通讯作者:
Roumeguère T
中科院分区:
文献类型:
--
作者:
Boudjeltia KZ;Delporte C;Van Antwerpen P;Franck T;Serteyn D;Moguilevsky N;Raes M;Vanhamme L;Vanhaeverbeek M;Van Meerhaeghe A;Roumeguère T
The present paradigm of atherogenesis proposes that low density lipoproteins (LDLs) are trapped in subendothelial space of the vascular wall where they are oxidized. Previously, we showed that oxidation is not restricted to the subendothelial location. Myeloperoxidase (MPO), an enzyme secreted by neutrophils and macrophages, can modify LDL (Mox-LDL) at the surface of endothelial cells. In addition we observed that the activation of the endothelial cells by angiotensin II amplifies this process. We suggested that induction of the NADPH oxidase complex was a major step in the oxidative process. Based on these data, we asked whether there was an independent association, in 121 patients, between NADPH oxidase modulators, such as angiotensin II, adiponectin, and levels of circulating Mox-LDL. Our observations suggest that the combination of blood angiotensin II, MPO activity, and adiponectin explains, at least partially, serum Mox-LDL levels.
登录
查看更多内容
影响因子:
3.7
作者:
Boudjeltia, Karim Zouaoui;Faraut, Brice;Kerkhofs, Myriam
通讯作者:
Kerkhofs, Myriam
影响因子:
3.1
作者:
Li, Hong;Cao, Zehong;Cheng, Guangjie
通讯作者:
Cheng, Guangjie
DOI:
10.1016/j.bbrc.2004.10.049
发表时间:
2004-12-10
影响因子:
3.1
作者:
Boudjeltia, KZ;Moguilevsky, N;Remacle, C
通讯作者:
Remacle, C
影响因子:
6.1
作者:
Delporte, Cedric;Franck, Thierry;Boudjeltia, Karim Zouaoui
通讯作者:
Boudjeltia, Karim Zouaoui
影响因子:
6.1
作者:
Franck, T.;Kohnen, S.;Serteyn, D.
通讯作者:
Serteyn, D.